EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹3,566 Cr | ₹3,449 Cr | ₹2,737 Cr | ₹2,523 Cr | ₹2,942 Cr |
What is the latest Total Non-Current Assets ratio of EMCURE PHARMACEUTICALS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹3,566 Cr |
| Mar2024 | ₹3,449 Cr |
| Mar2023 | ₹2,737 Cr |
| Mar2022 | ₹2,523 Cr |
| Mar2021 | ₹2,942 Cr |
How is Total Non-Current Assets of EMCURE PHARMACEUTICALS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,566 Cr | 3.37 | |
| Mar2024 | ₹3,449 Cr | 26.01 | |
| Mar2023 | ₹2,737 Cr | 8.49 | |
| Mar2022 | ₹2,523 Cr | -14.22 | |
| Mar2021 | ₹2,942 Cr | - | |
Compare Total Non-Current Assets of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹32,220.5 Cr | -1.5% | -4.9% | 26.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,349.0 Cr | -3% | -1.9% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,543.0 Cr | -3.3% | -0.7% | -1.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,884.0 Cr | -3.8% | 2.8% | 36.4% | Stock Analytics | |
| CIPLA | ₹111,077.0 Cr | -3% | 3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,388.0 Cr | -4.3% | -2% | 2.5% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -1.5% |
-4.9% |
26.2% |
| SENSEX | -2.2% |
-3.3% |
-8.8% |
You may also like the below Video Courses